Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Staub

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Hazardous Materials|May 11, 2010
Long-term moisture measurements in large-scale bioreactor cells using TDR and neutron probesM J Staub, J-P Gourc, J-P Laurent, et al.
Swiss Medical Weekly|December 8, 2005
Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function statesM Christ-Crain, N G Morgenthaler, C Meier, et al.
Oncogene|February 22, 2007
Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistanceJ Staub, J Chien, Y Pan, et al.
The American Journal of Medicine|June 1, 1992
Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissuesJ J Staub, B U Althaus, H Engler, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)C Meier, J J Staub, C B Roth, et al.
Cancer Research|May 19, 2001
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancerV Shridhar, K C Bible, J Staub, et al.
Schweizerische Medizinische Wochenschrift|August 6, 1996
[Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)]P Komminoth, S Muletta-Feurer, A Soltermann, et al.
Oncogene|September 23, 2008
A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformationJ Chien, K Narita, R Rattan, et al.
Oncogene|March 26, 2013
Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblastsS M Goicoechea, R García-Mata, J Staub, et al.
Vaccine|April 1, 1997
Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIBP M Mendelman, L Feeley, S Bird, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Hazardous Materials|May 11, 2010
Long-term moisture measurements in large-scale bioreactor cells using TDR and neutron probesM J Staub, J-P Gourc, J-P Laurent, et al.
Swiss Medical Weekly|December 8, 2005
Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function statesM Christ-Crain, N G Morgenthaler, C Meier, et al.
Oncogene|February 22, 2007
Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistanceJ Staub, J Chien, Y Pan, et al.
The American Journal of Medicine|June 1, 1992
Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissuesJ J Staub, B U Althaus, H Engler, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)C Meier, J J Staub, C B Roth, et al.
Cancer Research|May 19, 2001
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancerV Shridhar, K C Bible, J Staub, et al.
Schweizerische Medizinische Wochenschrift|August 6, 1996
[Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)]P Komminoth, S Muletta-Feurer, A Soltermann, et al.
Oncogene|September 23, 2008
A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformationJ Chien, K Narita, R Rattan, et al.
Oncogene|March 26, 2013
Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblastsS M Goicoechea, R García-Mata, J Staub, et al.
Vaccine|April 1, 1997
Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIBP M Mendelman, L Feeley, S Bird, et al.
Pageof 10